In September 2005, CBPE backed the MBO of IDIS, a market leading importer and supplier of unlicensed pharmaceuticals. Its core activity is the sourcing and supply (with appropriate regulatory approval) of drugs which are currently unlicensed within a domestic territory from an overseas territory where they are licensed.

IDIS, in partnership with pharmaceutical companies, and operating on a named-patient basis, provides these services to hospital and retail based pharmacists acting at the request of the prescribing hospital physician.

IDIS provides its services on an International basis.